US-based medical laboratory Clongen Laboratories announced on Monday that it will launch sister company Clongen Pharma LLC in March 2026

The new company is planned to develop novel, targeted cancer therapeutics.

Clongen Pharma LLC will be headquartered in Gaithersburg, MD, focusing on developing and evaluating technologies for the treatment of blood cancers and solid tumours. It will recruit scientists with relevant expertise in cancer biology and therapeutic approaches.

Further details, including the launch of the company website, will be provided in future updates.